Skip to main content
. 2022 May 26;11(6):719. doi: 10.3390/antibiotics11060719

Figure 3.

Figure 3

Forest plot of odds ratios for the comparisons of positive response rates between patients with pneumocystis pneumonia who received TMP–SMX + echinocandin combination therapy and those who received TMP–SMX monotherapy. echinocandin −, TMP–SMX monotherapy; echinocandin +, TMP–SMX + echinocandin combination therapy; M–H, Mantel–Haenszel; CI, confidence interval; OR, odds ratio; SMX, sulfamethoxazole; TMP, trimethoprim.